Related Experiment Video

Updated: Aug 6, 2026

Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates
05:58

Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to Neonates

Published on: September 6, 2017

Metabolism of antiepileptic medication: newborn to elderly

I E Leppik1

  • 1Department of Neurology, University of Minnesota Medical School, Minneapolis.

Epilepsia
|January 1, 1992
PubMed

Insights

Antiepileptic drug (AED) dosages and side effects vary significantly across age groups, necessitating tailored treatment strategies. Understanding age-related metabolic changes is crucial for effective epilepsy management in children, adults, and the elderly.

Area of Science:

  • Pharmacology
  • Neurology
  • Geriatrics

Background:

  • Epilepsy treatment requires age-specific antiepileptic drug (AED) regimens.
  • Metabolism and side-effect profiles of AEDs differ substantially between infants, children, adults, and the elderly.

Purpose of the Study:

  • To highlight the critical need for epileptologists to understand age-related changes in AED metabolism.
  • To guide appropriate AED dosing and management strategies across the lifespan.

Main Methods:

  • Review of pharmacokinetic and pharmacodynamic differences in AEDs across pediatric, adult, and geriatric populations.
  • Analysis of age-specific metabolic rates, drug half-lives, and metabolite profiles.
  • Examination of differential vulnerability to AED adverse effects based on age.

Main Results:

  • Children generally exhibit faster metabolic rates and shorter AED half-lives, requiring higher mg/kg dosages (e.g., phenytoin).
  • Neonates, infants, and children show slower AED elimination rates.
  • The elderly may require lower dosages and are more susceptible to neurotoxic effects and specific adverse events like hyponatremia from carbamazepine.

Conclusions:

  • Age-dependent alterations in AED metabolism and elimination necessitate individualized dosing.
  • Valproate metabolism differs by age, potentially influencing hepatotoxicity profiles.
  • Elderly patients require careful AED selection and monitoring due to increased vulnerability to adverse effects.

More Related Videos

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats During EEG Recordings10:46

Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats During EEG Recordings

Published on: September 1, 2023

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...